The Impact of Comorbidities and Clinical Characteristics on Real-World Mepolizumab Effectiveness in Patients with Severe Asthma: Results from the REALITI-A Study

MLA

G.L. Chupp, et al. “The Impact of Comorbidities and Clinical Characteristics on Real-World Mepolizumab Effectiveness in Patients with Severe Asthma: Results from the REALITI-A Study.” C101. EXPANDING THE USE OF ASTHMA BIOLOGICS AND OTHER NOVEL THERAPEUTICS TO ADDITIONAL PATIENT POPULATIONS, May 2022. EBSCOhost, https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4836.

APA

G.L. Chupp, L.G. Heaney, G. Pelaia, T. Welte, C. Almonacid Sanchez, J.K. Lee, A. Maxwell, R.G. Price, R.W. Jakes, R. Alfonso Cristancho, P. Howarth, & G. Brusselle. (2022). The Impact of Comorbidities and Clinical Characteristics on Real-World Mepolizumab Effectiveness in Patients with Severe Asthma: Results from the REALITI-A Study. C101. EXPANDING THE USE OF ASTHMA BIOLOGICS AND OTHER NOVEL THERAPEUTICS TO ADDITIONAL PATIENT POPULATIONS. https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4836

Chicago

G.L. Chupp, L.G. Heaney, G. Pelaia, T. Welte, C. Almonacid Sanchez, J.K. Lee, A. Maxwell, et al. 2022. “The Impact of Comorbidities and Clinical Characteristics on Real-World Mepolizumab Effectiveness in Patients with Severe Asthma: Results from the REALITI-A Study.” C101. EXPANDING THE USE OF ASTHMA BIOLOGICS AND OTHER NOVEL THERAPEUTICS TO ADDITIONAL PATIENT POPULATIONS, May. doi:10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4836.